TP53 Mutations and TET2 Deficiency Cooperate to Drive Leukemogenesis and Establish an Immunosuppressive Environment.
Pu Zhang, Ethan C Whipp, Sarah J Skuli,Mehdi Gharghabi,Caner Saygin, Steven A Sher,Martin Carroll, Xiangyu Pan, Eric D Eisenmann, Tzung-Huei Lai,Bonnie K Harrington, Wing Keung Chan, Youssef, Bingyi Chen, Alex Penson, Alexander M Lewis, Cynthia R Castro, Nina Fox, Ali Cihan, Jean-Benoit Le Luduec,Susan DeWolf, Tierney Kauffman,Alice S Mims, Daniel Canfield,Hannah Phillips, Katie E Williams, Jami Shaffer,Arletta Lozanski, Tzyy-Jye Doong,Gerard Lozanski, Charlene Mao,Christopher J Walker,James S Blachly,Anthony F Daniyan,Lapo Alinari,Robert A Baiocchi,Yiping Yang,Nicole R Grieselhuber,Moray J Campbell,Sharyn D Baker,Bradley W Blaser,Omar Abdel-Wahab, Rosa Lapalombella The Journal of clinical investigation（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper